Geun‐woo Jin

774 total citations
30 papers, 606 citations indexed

About

Geun‐woo Jin is a scholar working on Molecular Biology, Biomaterials and Infectious Diseases. According to data from OpenAlex, Geun‐woo Jin has authored 30 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Biomaterials and 4 papers in Infectious Diseases. Recurrent topics in Geun‐woo Jin's work include RNA Interference and Gene Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Geun‐woo Jin is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Geun‐woo Jin collaborates with scholars based in South Korea, Japan and United Kingdom. Geun‐woo Jin's co-authors include Heebeom Koo, Yan Lee, Jong‐Sang Park, Jin‐Ho Choy, N. Sanoj Rejinold, Heejung Mo, Hyun-Seo Kang, Goeun Choi, Huiyan Piao and Kihoon Nam and has published in prestigious journals such as Nature Communications, Nano Letters and Biomaterials.

In The Last Decade

Geun‐woo Jin

27 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geun‐woo Jin South Korea 11 290 149 103 99 98 30 606
Rosemeyre A. Cordeiro Portugal 14 301 1.0× 282 1.9× 121 1.2× 223 2.3× 83 0.8× 19 744
Regina Reul Germany 14 291 1.0× 215 1.4× 132 1.3× 107 1.1× 54 0.6× 16 641
Ajit Joseph M. D'Souza United States 8 191 0.7× 127 0.9× 65 0.6× 97 1.0× 28 0.3× 11 423
Mayank Bhavsar United States 8 301 1.0× 202 1.4× 50 0.5× 81 0.8× 99 1.0× 10 657
Ken‐ichiro Hiwatari Japan 15 304 1.0× 171 1.1× 90 0.9× 88 0.9× 23 0.2× 30 608
Hua-fen Wang China 13 281 1.0× 190 1.3× 133 1.3× 173 1.7× 68 0.7× 21 578
D. Ibraheem France 6 341 1.2× 124 0.8× 27 0.3× 107 1.1× 99 1.0× 7 527
Woei Ping Cheng United Kingdom 12 186 0.6× 184 1.2× 77 0.7× 101 1.0× 20 0.2× 14 465
Michèle Léonard France 9 219 0.8× 141 0.9× 58 0.6× 92 0.9× 149 1.5× 13 522
Seok Min Kwon South Korea 8 282 1.0× 279 1.9× 43 0.4× 163 1.6× 49 0.5× 15 645

Countries citing papers authored by Geun‐woo Jin

Since Specialization
Citations

This map shows the geographic impact of Geun‐woo Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geun‐woo Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geun‐woo Jin more than expected).

Fields of papers citing papers by Geun‐woo Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geun‐woo Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geun‐woo Jin. The network helps show where Geun‐woo Jin may publish in the future.

Co-authorship network of co-authors of Geun‐woo Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Geun‐woo Jin. A scholar is included among the top collaborators of Geun‐woo Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geun‐woo Jin. Geun‐woo Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rejinold, N. Sanoj, Geun‐woo Jin, & Jin‐Ho Choy. (2025). Harnessing Nanohybridized Niclosamide for Precision Mpox Therapeutics (Adv. Healthcare Mater. 14/2025). Advanced Healthcare Materials. 14(14). 1 indexed citations
2.
Kim, Jung Ho, Shin‐Woo Kim, Dae Won Park, et al.. (2025). A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19. Nature Communications. 16(1). 7084–7084. 1 indexed citations
3.
Rejinold, N. Sanoj, Geun‐woo Jin, & Jin‐Ho Choy. (2025). Harnessing Nanohybridized Niclosamide for Precision Mpox Therapeutics. Advanced Healthcare Materials. 14(14). e2404818–e2404818. 2 indexed citations
4.
Rejinold, N. Sanoj, Ji‐Yeong Kim, Geun‐woo Jin, Goeun Choi, & Jin‐Ho Choy. (2025). Transport Mechanisms of 2D Nanoparticles across a Human Follicle-Associated Epithelium Model. ACS Omega. 10(36). 40901–40912.
5.
Jin, Geun‐woo, et al.. (2024). Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study. Biomedicine & Pharmacotherapy. 173. 116394–116394. 5 indexed citations
6.
Rejinold, N. Sanoj, Geun‐woo Jin, & Jin‐Ho Choy. (2024). Insight into Preventing Global Dengue Spread: Nanoengineered Niclosamide for Viral Infections. Nano Letters. 24(46). 14541–14551. 7 indexed citations
7.
Rejinold, N. Sanoj, Huiyan Piao, Geun‐woo Jin, Goeun Choi, & Jin‐Ho Choy. (2021). Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy. Colloids and Surfaces B Biointerfaces. 208. 112063–112063. 9 indexed citations
8.
Piao, Huiyan, et al.. (2021). Niclosamide encapsulated in mesoporous silica and geopolymer: A potential oral formulation for COVID-19. Microporous and Mesoporous Materials. 326. 111394–111394. 16 indexed citations
9.
Piao, Huiyan, et al.. (2021). Niclosamide–Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment. Polymers. 13(7). 1044–1044. 30 indexed citations
10.
Rejinold, N. Sanoj, Huiyan Piao, Goeun Choi, Geun‐woo Jin, & Jin‐Ho Choy. (2021). Niclosamide-Exfoliated Anionic Clay Nanohybrid Repurposed as an Antiviral Drug for Tackling Covid-19; Oral Formulation with Tween 60/Eudragit S100. Clays and Clay Minerals. 69(5). 533–546. 8 indexed citations
11.
Choi, Goeun, et al.. (2021). Hydrotalcite–Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections. Pharmaceuticals. 14(5). 486–486. 21 indexed citations
12.
Ma, Weili, Geun‐woo Jin, & Won Hyuck Suh. (2015). Development of hyaluronic acid hydrogels for human neural stem cell engineering. 1–2. 1 indexed citations
13.
Jin, Geun‐woo & Younsoo Bae. (2013). Reductant-dependent None-Partial-Complete Degradation of Block Copolymer Disulfide Crosslinked Nanoassemblies. 2 indexed citations
14.
Nam, So Hee, et al.. (2011). Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin. International Journal of Pharmaceutics. 419(1-2). 114–120. 32 indexed citations
15.
Jin, Geun‐woo, et al.. (2011). Effect of deoxycholate conjugation on stability of pDNA/polyamidoamine-diethylentriamine (PAM-DET) polyplex against ionic strength. International Journal of Pharmaceutics. 420(2). 366–370. 2 indexed citations
16.
Park, Ji‐Hye, et al.. (2011). Spectrofluorimetric Determination of Alendronate by Conjugation with the Rhodamine B Sulfonyl Group. Bulletin of the Korean Chemical Society. 32(5). 1777–1780. 8 indexed citations
17.
Koo, Heebeom, Geun‐woo Jin, Hyun-Seo Kang, et al.. (2009). A new biodegradable crosslinked polyethylene oxide sulfide (PEOS) hydrogel for controlled drug release. International Journal of Pharmaceutics. 374(1-2). 58–65. 45 indexed citations
18.
Koo, Heebeom, Geun‐woo Jin, Hyun-Seo Kang, et al.. (2009). Biodegradable branched poly(ethylenimine sulfide) for gene delivery. Biomaterials. 31(5). 988–997. 57 indexed citations
19.
Jin, Geun‐woo. (2009). Preparation of Naproxen-Loaded Poly(ethylene oxide-b-methacrylic acid) Micelle and Its pH-dependent Drug Release Behavior. Bulletin of the Korean Chemical Society. 30(4). 931–934. 4 indexed citations
20.
Lee, Yan, et al.. (2006). Visualization of the Degradation of a Disulfide Polymer, Linear Poly(ethylenimine sulfide), for Gene Delivery. Bioconjugate Chemistry. 18(1). 13–18. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026